JPMorgan Chase & Co’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,041,718
| Closed | -$309M | – | 6342 |
|
2022
Q3 | $309M | Buy |
2,041,718
+1,165,134
| +133% | +$176M | 0.04% | 353 |
|
2022
Q2 | $128M | Sell |
876,584
-492,949
| -36% | -$71.8M | 0.02% | 617 |
|
2022
Q1 | $162M | Sell |
1,369,533
-25,592
| -2% | -$3.03M | 0.02% | 600 |
|
2021
Q4 | $192M | Sell |
1,395,125
-64,614
| -4% | -$8.9M | 0.02% | 544 |
|
2021
Q3 | $203M | Sell |
1,459,739
-292,129
| -17% | -$40.6M | 0.03% | 537 |
|
2021
Q2 | $170M | Sell |
1,751,868
-2,588
| -0.1% | -$251K | 0.02% | 615 |
|
2021
Q1 | $120M | Buy |
1,754,456
+78,494
| +5% | +$5.37M | 0.02% | 714 |
|
2020
Q4 | $144M | Buy |
1,675,962
+14,551
| +0.9% | +$1.25M | 0.02% | 603 |
|
2020
Q3 | $105M | Buy |
1,661,411
+53,557
| +3% | +$3.38M | 0.02% | 631 |
|
2020
Q2 | $118M | Buy |
1,607,854
+72,409
| +5% | +$5.29M | 0.02% | 574 |
|
2020
Q1 | $52.3M | Buy |
1,535,445
+100,852
| +7% | +$3.43M | 0.01% | 736 |
|
2019
Q4 | $78.1M | Sell |
1,434,593
-99,851
| -7% | -$5.44M | 0.01% | 696 |
|
2019
Q3 | $64M | Sell |
1,534,444
-12,268
| -0.8% | -$512K | 0.01% | 764 |
|
2019
Q2 | $65.8M | Sell |
1,546,712
-222,901
| -13% | -$9.48M | 0.01% | 772 |
|
2019
Q1 | $91.1M | Sell |
1,769,613
-126,347
| -7% | -$6.5M | 0.02% | 630 |
|
2018
Q4 | $70.1M | Buy |
1,895,960
+363,599
| +24% | +$13.4M | 0.02% | 684 |
|
2018
Q3 | $57.5M | Buy |
1,532,361
+105,913
| +7% | +$3.98M | 0.01% | 861 |
|
2018
Q2 | $56.4M | Buy |
1,426,448
+509,105
| +55% | +$20.1M | 0.01% | 823 |
|
2018
Q1 | $23.6M | Sell |
917,343
-1,937
| -0.2% | -$49.9K | 0.01% | 1261 |
|
2017
Q4 | $24.8M | Buy |
919,280
+441,027
| +92% | +$11.9M | 0.01% | 1254 |
|
2017
Q3 | $18.2M | Sell |
478,253
-114,972
| -19% | -$4.37M | ﹤0.01% | 1393 |
|
2017
Q2 | $14.8M | Buy |
+593,225
| New | +$14.8M | ﹤0.01% | 1474 |
|